Medical Devices & Surgical Technology Week articles from December 2004

Medical Devices & Surgical Technology Week archives from December 2004

Efficacy of heparin-coated angiographic catheters compared.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The influence of coating method on the efficacy of heparin-coated angiographic catheters has been determined. In a recent study, radiologists in South Korea "evaluated in vivo anti-thrombogenic...

Novel technique prevents early postoperative capsular block syndrome.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A novel capsulotomy technique reduces the risk of capsular block syndrome (CBS). Ophthalmologists in Venezuela devised "a new surgical technique, intraoperative peripheral anterior capsulotomy...

Fine-tip Dermabond application technique improves esthetic results.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A novel fine-tip Dermabond application technique can improve the esthetic outcome of craniofacial surgery. "Tissue glues and adhesives have achieved increasing popularity as alternatives to small...

Dose response characteristics of novel GafChromic films determined.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The dose response characteristics of several GafChromic films have been determined. Scientists in New York conducted a "systematic study of the dose response characteristics of two new models and...

Effect of low-frequency ultrasound on skin permeability clarified.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The effects of low-frequency ultrasound on skin permeability and electrical resistance have been elucidated. "Transdermal drug delivery offers an alternative to injections and oral medication but...

High-dose melphalan and ASCT improves quality of life of AL amyloidosis patients.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- High-dose melphalan and autologous peripheral blood stem cell transplantation improves the quality of life of AL amyloidosis patients. According to a study from the United States, "Treatment of AL...

AML samples with FLT3/ITD mutations preferentially killed by FLT3 inhibition.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Pediatric acute myelogenous leukemia samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition. According to recent research from the United States, "Pediatric acute myelogenous...

Idarubicin and busulfan feasible for elderly AML patients undergoing ASCT.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Continuous infusion of idarubicin and oral busulfan is feasible for elderly patients with acute myeloid leukemia undergoing autologous stem cell transplantation. According to recent research from...

Effects of noxious stimulation during sevoflurane anesthesia characterized.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The effects of noxious stimulation during sevoflurane anesthesia have been characterized using a novel technique. "In 21 patients given sevoflurane anesthesia," anesthesiologists in Sweden...

Propofol doesn't disrupt lidocaine metabolism during epidural anesthesia.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Propofol doesn't disrupt lidocaine metabolism during epidural anesthesia. According to recent research from Japan, "[p]ropofol is sometimes used in combination with epidural anesthesia with...

Volatile anesthetics cause blood flow-dependent changes in renal NO levels.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Volatile anesthetics cause blood flow-dependent changes in renal NO levels. Scientists in Japan "previously demonstrated that intrarenal nitric oxide (NO) levels and renal blood flow are reduced...

Endothelin-1 may contribute to I/R-induced muscle damage.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Endothelin-1 (ET-1) appears to contribute to ischemia/reperfusion-induced muscle damage. "Tourniquet-induced ischemia is often used in orthopedic and reconstructive procedures," surgeons in England...

Endovascular stenting lowers risk of restenosis in intracranial VBA.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Endovascular stenting lowers the risk of restenosis in the intracranial vertebrobasilar artery (VBA). "Percutaneous transluminal balloon angioplasty (PTA) has been used in the treatment of critical...

Company gets $877.5 million U.S. government contract to supply anthrax vaccine.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc. (VXGN) announced that the U.S. government has awarded the company an $877.5 million contract to supply 75 million doses of anthrax vaccine for civilian defense. The contract, the first...

Inhaled CO has anti-inflammatory effects against ventilator-induced lung injury.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Inhaled carbon monoxide has antiinflammatory effects against ventilator-induced lung injury. "Ventilator-induced lung injury (VILI) is a major cause of morbidity and mortality in intensive care...

Women with arrhythmias may also benefit from an ICD.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A small study of patients with heart failure not caused by blocked arteries indicates that women, as well as men, may benefit from implantable cardioverter-defibrillators (ICD), reported researchers at...

Novel capillary electrophoresis immunoassay developed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A novel capillary electrophoresis immunoassay (CEIA) has been developed and evaluated. A CEIA method "based on enhanced chemiluminescence (CL) detection" was devised by scientists in China, and...

Pharmaceutical firm withdraws Symbicort file for European Union.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- AstraZeneca announced that it has withdrawn its Symbicort Single Inhaler Therapy file for the European Union. As a result of discussions during the Mutual Recognition Process, AstraZeneca expects a...

C-reactive protein level rises after renal stent implantation.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- C-reactive protein (CRP) level rises in after renal stent implantation in patients with atherosclerotic stenosis. Elevated CRP level "has been demonstrated in patients with coronary artery disease...

CryoBlator approved for use in U.S. trials, CE marked in Europe.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- CryoCor, Inc., a development-stage medical technology company, announced that it has received U.S. Food and Drug Administration approval to use its Model 1200 (CryoBlator) series of cardiac catheters in...

Beacon Award given to N. California business for nutrition and eye health CD.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- ScienceBased Health, a provider of premium nutraceuticals for eye health, has received the Beacon Award from the Northern California Business Marketing Association. The award was given for the...

Clinical diagnostics company receives technology award.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- SomaLogic, Inc., a privately held proteomics company, announced that it has received Frost & Sullivan's 2004 Technology Innovation Award in the field of biomarkers. In its recent study, Biomarkers:...

Frost & Sullivan awards Health Buddy system developer for product innovation.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Frost & Sullivan's recent research analysis, U.S. Remote Patient Monitoring Devices Markets, selected Health Hero Network, Inc., as the recipient of the 2004 Product Innovation Excellence Award for...

Thin strips for cold and cough medicine delivery receive best product award.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Three weeks after their official launch, Triaminic and Theraflu Thin Strips have been named "Best Product of 2004" by Convenience Industry News (CIN) magazine. Thin Strips, a multi-symptom cough...

UC Davis selected as Sun Center of Excellence in Public Health and Safety.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Recognizing University of California, Davis, for its contribution to health and safety research and technology, Sun Microsystems, Inc. (SUNW) announced its selection of UC Davis as a Center of...

Indian Salmonella Typhi isolates have reduced ciprofloxacin susceptibility.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Salmonella Typhi isolates in India have reduced susceptibility to ciprofloxacin. "Typhoid fever continues to remain a health problem as the causative organism Salmonella Typhi has developed...

Bacterial resistance to solvents, biodesulfurization activity relation studied.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The relation between bacterial strain resistance to solvents and biodesulfurization activity has been studied in organic media. According to researchers in France, "Microorganisms used in...

Bioreactor efficient, promising for study of chlororespiration enzymes.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- High biomass has been generated from chlororespiring bacteria using a continuous fed-batch bioreactor. According to recent research published in the journal Applied Microbiology and Biotechnology,...

Dehydration behavior of bacteria in liquid medium studied in drying process.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A new drying process for lactic bacteria based on their dehydration behavior in liquid medium was the focus of a recent report. Researchers in France describe "the different stages of optimization...

High-throughput method for counting bacterial colonies developed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Scientists have developed a method for high-throughput imaging of bacterial colonies grown on 96-well filter plates. "The ability to accurately enumerate viable bacteria has applications in...

NO-releasing sol-gel may aid in studies of localized NO release on other systems.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Nitric oxide-releasing sol-gel may be useful in studies of localized nitric oxide release on other chemical and biological systems. "Nitric oxide (NO) releasing sol-gel materials coated with...

Pneumococcal virulence factor contributions to pathogenesis studied in mice.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Tissue-specific contributions of pneumococcal virulence factors to pathogenesis have been studied in a murine mode. Scientists in the United States "assessed the ability of Streptococcus pneumoniae...

Synthetic peptide used to study antibacterial drug class activity.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Synthetic peptide has been used to study the activity of an antibacterial drug class. "The coumarin antibiotics are potent inhibitors of DNA replication whose target is the enzyme DNA gyrase, an...

MTT/ATP/calcein assays similarly predict potency of cytotoxic anticancer agents.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- MTT, ATP and calcein assays similarly predict the potency of cytotoxic anticancer agents. "Cell viability assays are important tools in oncological research and clinical practice to assess the tumor...

Pinched flow fractionation assay developed for particle separation.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A novel device based on pinched flow fractionation has been developed for particle separation and analysis. According to recent research from Japan, a "concept of 'pinched flow fractionation' for...

Company enters blood-bank market with new Lasette.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Cell Robotics International, Inc., (CRII) announced that it anticipates significant sales of its proprietary Lasette product to the blood-banking community based on the product's reception at the 2004...

Murine model developed for bone marrow failure.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A murine model was developed for bone marrow failure. According to a study from the United States, "Infusion of parental lymph node (LN) cells into sublethally irradiated hybrid F1 recipients...

Chromosome 17 genes with abnormal expression identified.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A number of chromosome 17 genes with altered expression in breast cancer have been identified. "Chromosome 17 is severely rearranged in breast cancer," oncologists in France explained. "Whereas the...

Femara gets U.S. FDA nod as post-tamoxifen treatment for early breast cancer.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Femara (letrozole tablets) is the first therapy approved by the U.S. Food and Drug Administration for the extended adjuvant treatment of postmenopausal women with early breast cancer who have received...

Intra-operative specimen radiographs help minimize necessary tissue excision.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Intra-operative specimen radiographs help surgeons determine adequacy of excision margins while minimizing the amount tissue removed during breast-conserving surgery. "The ultimate goal of...

Pilot study examines new radiofrequency ablation-assisted lumpectomy.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The University of Arkansas for Medical Sciences (UAMS) and RITA Medical Systems, Inc. (Nasdaq:RITA) announced that the first patient in a planned series of 30 received a radiofrequency ablation-assisted...

Study assesses early cancer deaths in women aged 40-74 years in north Sweden.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- An analysis of lethal breast cancer cases in northern Sweden found that that most deaths occurred in women whose disease had already reached an advanced stage when the cancer was detected. P....

Tc-99m-MIBI scintimammography inappropriate for routine evaluation of lesions.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Study results suggest Tc-99m-MIBI scintimammography is inappropriate for routine evaluation of breast microcalcifications detected by standard mammography. Researchers in France wanted to determine...

System lowers breast augmentation re-operation rate by 17%.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Plastic surgeons can reduce breast implant re-operations in augmentation patients to 3% by following a new system of decision and management algorithms, according to a new report. At the same time,...

No correlation between B. cepacia complex wbiI RFLP genotype and species.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- There is no correlation between the Burkholderia cepacia complex wbiI RFLP genotype and species. According to recent research from the United States, "Gram-negative bacteria of the Burkholderia...

Intensive/short-term Burkitt lymphoma chemotherapy effective/manageable toxicity.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Intensive/short-term chemotherapy for Burkitt's lymphoma is effective and has manageable toxicity. "A very short, intensive pediatric chemotherapy program was tested in a consecutive...

Ambulatory surgery management company reports results.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- NovaMed, Inc., (NASDAQ: NOVA) reported results for the third quarter and 9 months ended September 30, 2004. Net income from continuing operations in the third quarter of 2004 increased 34% to...

Biopharma company presents data on NeoLipid compound, releases financial results.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- NeoPharm (Nasdaq:NEOL) announced that preliminary data from a phase I clinical trial of the company's NeoLipid compound LEP-ETU were presented at the 29th Congress of the European Society for Medical...

Drug delivery company reports third quarter 2004 financial results.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Penwest Pharmaceuticals Co. (NASDAQ:PPCO) announced its financial results for the third quarter and the 9 months ended September 30, 2004. Total revenues for the third quarter of 2004 were $1.2...

Haemonetics makes equity investment, enters research collaboration.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Haemonetics Corp. (HAE) and Arryx, Inc., announced they will collaborate on the development of new technology for applications in a broad range of markets. Haemonetics will make an equity...

Information technology company announces financial results, personnel changes.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- QuadraMed Corporation (AMEX:QD) announced its third quarter 2004 financial results. Revenues were $32 million for the third quarter, representing an increase of 8% over the same period in 2003. Net...

Ophthalmic imaging company reports financial results.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Ophthalmic Imaging Systems (OTCBB:OISI) reported its financial results for the third quarter ended September 30, 2004. The company reported net revenues of $2,615,000 for the third quarter of 2004,...

Oral fluid diagnostics company announces financial results.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- OraSure Technologies, Inc., (Nasdaq:OSUR) announced its financial results for the quarter and 9 months ended September 30, 2004. Total revenues for the third quarter of 2004 increased 37% to $14.2...

Pharma company reports third quarter 2004 results.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Point Therapeutics, Inc., (NASDAQ: POTP) reported results for the fiscal quarter and 9 months ended September 30, 2004. During the third quarter of 2004, Point achieved the following key...

Radiation therapy services provider reports third quarter 2004 results.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Radiation Therapy Services, Inc., (NASDAQ:RTSX) announced its financial results for the third quarter and 9 months ended September 30, 2004. Total revenues for the third quarter were $40.7 million,...

Technology company announces trading symbol change.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Ingen Technologies, Inc., received confirmation from the NASD of its trading symbol change to OTC: IGTN. The change was effective November 2, 2004. President Scott Sand said, "This new trading...

Ambulatory surgery company announces delay in closing deal, progress on centers.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Ambulatory surgery company SurgiCare Inc. (SRG) has completed syndication of Tuscarawas Open MRI Center located in Dover, Ohio. SurgiCare is also in the final stages of re-syndicating the Memorial...

Care management software company relocates U.S. headquarters.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- MEDecision Inc. announced the relocation of its U.S. headquarters, thereby strengthening the company's commitment to advancing its integrated medical management (IMM) solution. "We are spreading...

Company shutdown leaves agencies scrambling for equipment.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The sudden shutdown of a Massachusetts manufacturer of defibrillators has left some Wisconsin agencies scrambling to replace the lifesaving devices in their emergency vehicles. Access CardioSystems...

Diagnostic company discontinues orthopedic division to focus on cancer products.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Lifeline Biotechnologies announced that it intends to focus its efforts solely on the cancer products it has under development. According to the announcement, Lifeline's cancer products include the...

Disease management product company gets award.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Cardiocom, a provider of disease management and remote monitoring products, announced that they are the recipients of the 2004 Disease Management Association of America (DMAA) award for the "Best...

Enterprise provider hits $20M milestone in medical device market.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Camstar Systems, Inc., a provider of enterprise manufacturing and quality systems for life sciences and other global manufacturers, announced that it has secured $20 million in orders from medical...

Hatch Medical retained by German orthopedic biotech.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Hatch Medical, LLC, a medical-device incubator and technology brokerage firm, announced that it has been retained by German orthopedic biotechnology firm Ossacur, AG, (Oberstenfeld, Germany) to identify...

Lab equipment maker reports work on ReCell meets expectations.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Clinical Cell Culture, Ltd., (C3, CCE) provided an update regarding the company's commercialization plans. C3 reported that validation work, clinical and stability data obtained for ReCell...

Medical products distributor selects marketing partner.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Profex Medical Products has selected Kupper Parker Communications, Inc., (BULLETIN BOARD: KPCG) as its marketing partner. Through a comprehensive marketing communications plan, KPC will provide...

Medical safety developer announces large safety syringe order.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Maxxon, Inc., (OTC:MXON) announced that its manufacturing and distribution partner, Globe Medical Tech, Inc., of Houston, Texas, has received four signed purchase orders for a total of 6 million units...

Pharmaceutical company free to provide exclusive license to Boston Scientific.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Angiotech Pharmaceuticals, Inc., (ANPI, ANP) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR) has expired pertaining to the proposed grant of an exclusive...

Phosphonates supplier to pharmaceutical cos., others announces price increase.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Solutia Inc. (SOLUQ) has announced a price increase for all of its Dequest phosphonates. This increase applies to all orders shipped on or after Nov. 1, 2004. Dequest brand phosphonates are highly...

Spin-Off of AngioDynamics completed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- E-Z-EM, Inc., (EZM) announced the completion of the spin-off of AngioDynamics, Inc. On October 30, 2004, E-Z-EM distributed 0.856377 of a share of AngioDynamics common stock as a dividend on each...

Nonionizing and ionizing radiation inactivate Calicivirus.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Nonionizing and ionizing radiation inactivate Calicivirus. According to a study from the Netherlands, "Noroviruses (previously Norwalk-like viruses) are the most common viral agents associated with...

Cleveland Clinic installs BioScanIR System to monitor cancer therapy response.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- OmniCorder Technologies, Inc., (OMCT) announced the delivery of a new cancer therapy monitoring configuration of its BioScanIR System to The Cleveland Clinic. The system will be used to detect the...

ResQ-valve with CPR improves survival rate in cardiac arrest patients.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- A Medical College of Wisconsin research team, led by emergency physicians Tom P. Aufderheide and Ronald G. Pirrallo, has found that adding a simple device called the ResQ-Valve to standard CPR...

Cardiac troponins/NT-proBNP prognostic of amyloidosis PBSCT survival.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Cardiac troponins and N-terminal probrain natriuretic peptide are prognostic of survival for amyloidosis patients following peripheral blood stem cell transplantation. "Primary systemic amyloidosis...

Cardiac catheterizations can be performed safely in a mobile laboratory.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Researchers have reported on the safety of performing diagnostic cardiac catheterizations in a mobile catheterization laboratory at primary care hospitals. Scientists writing in the journal...

Artificial hearts implanted in critically ill patients at Australian hospital.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Ventracor Limited (VCR) announced that two implants of its artificial heart had been performed at St Vincent's Hospital, Sydney, Australia. The implants were performed as part of a global trial to...

Medical device maker announces 1.5 millionth mechanical heart valve implant.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- St. Jude Medical, Inc. (STJ) announced the 1.5 millionth implant of its St. Jude Medical mechanical heart valve, an achievement for prosthetic heart valves. The procedure, performed by chairman and...

Gene expression after transverse aortic constriction characterized in mice.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Gene expression after transverse aortic constriction has been characterized in a murine model. "Cardiac hypertrophy is a compensatory response initially beneficial to heart function but can...

Gene expression in cardiac endothelia characterized.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The gene expression profiles of cardiac endothelial cells have been determined. "In addition to a number of common features, cardiovascular endothelium displays structural, functional, and genetic...

Deleterious hematological effects of CBP centrifugal pumps compared.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The deleterious hematological effects of two cardiopulmonary bypass (CPB) centrifugal pumps have been compared. CPB "induces hemolysis and the activation of the inflammatory and coagulation...

Direct stent implantation reduces myocardial injury.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Direct coronary stent implantation reduces the risk of myocardial injury. "Direct coronary stenting without balloon predilation has the potential benefits of a reduced risk of extended dissections,...

Effects of transvenous pacing on cardiac troponin release determined.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The effects of transvenous pacing on cardiac troponin release have been characterized. "Cardiac troponins are invaluable tools for the detection of minimal myocardial injury," scientists in England...

Factors underlying atherosclerosis in slow coronary flow patients determined.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Factors underlying atherosclerosis development in patients with slow coronary flow (SCF) have been identified. Researchers in Turkey conducted a study "to evaluate whether there was an imbalance...

Pharma company granted rights to thrombolytic agent, names executives.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- Nuvelo, Inc., (Nasdaq: NUVO) announced that it will gain worldwide rights to develop and commercialize the novel acting thrombolytic agent, alfimeprase, from Amgen Inc. in exchange for payment of...

Prognosis and treatment of commotio cordis reviewed.
December 5, 2004... 2004 DEC 5 - (NewsRx.com & NewsRx.net) -- The prognosis and treatment of commotio cordis has been reviewed. "Commotio cordis is ventricular fibrillation that results from blunt chest trauma and is a life threatening condition; early...